TrialAIDS (London, England)2015

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination.

As'ad E Bhorat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.